Surrogate endpoint

Results: 164



#Item
31Medicine / Health / Medical statistics / Design of experiments / Clinical trials / Surrogate endpoint / National Heart /  Lung /  and Blood Institute / Postherpetic neuralgia / Clinical endpoint / Clinical research / Research / Epidemiology

Microsoft Word - The Pediatric Heart Network - A Primer for the Conduct of Multicenter Studies in Children with Congenital and

Add to Reading List

Source URL: www.pediatricheartnetwork.org

Language: English - Date: 2014-07-08 10:01:14
32Medical research / Clinical trials / Epidemiology / Medical terms / Pharmacology / Biomarker / Surrogate endpoint / Validation / Food and Drug Administration / Medicine / Biology / Health

Companion Diagnostic Guidance

Add to Reading List

Source URL: www.fda.gov

Language: English
33Clinical trials / Epidemiology / Medical research / Medical terms / Prodrugs / Biomarker / Irinotecan / Surrogate endpoint / CYP3A4 / Medicine / Chemistry / Health

Topic 1 Pharmacogenetics of Irinotecan: Scientific and Clinical Impact of UGT Polymorphism 1. Is the pharmacokinetic and clinical evidence presented sufficient to demonstrate that homozygous UGT1A1*28 genotypes (7/7 ge

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2004-10-14 14:44:52
34Medical statistics / Prostate cancer / End point of clinical trials / Prostate / Surrogate endpoint / Cancer / Prostate cancer screening / Prostate-specific antigen / Medicine / Health / Clinical trials

V.  QUESTIONS FOR THE PANEL    In addressing the following premarket questions, please keep in mind that the ultimate  goal of these studies is to collect sufficient premarket clinical data 

Add to Reading List

Source URL: www.fda.gov

Language: English
35Clinical trials / Epidemiology / Medical research / Medical terms / Prodrugs / Biomarker / Irinotecan / Surrogate endpoint / CYP3A4 / Medicine / Chemistry / Health

Topic 1 Pharmacogenetics of Irinotecan: Scientific and Clinical Impact of UGT Polymorphism 1. Is the pharmacokinetic and clinical evidence presented sufficient to

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2004-10-14 14:44:52
36Minimal residual disease / Imatinib / Chemotherapy / Medicine / Piperazines / Philadelphia chromosome

MRD as a Surrogate Endpoint for Efficacy Evaluation of New Drugs in Very High Risk ALL: Lessons from Ph+ ALL FDA Meeting; April 18th, 2012 Stephen P. Hunger, M.D. Chair, COG ALL Committee

Add to Reading List

Source URL: www.fda.gov

Language: English
37Clinical research / FDA Fast Track Development Program / Surrogate endpoint / Center for Drug Evaluation and Research / Imaging biomarker / Food and Drug Administration / Medicine / Health

Gastrointestinal Drugs Advisory Committee Meeting NSAID-Associated Gastric and/or Duodenal Ulcers as Endpoints to Support Product Labeling November 4, 2010

Add to Reading List

Source URL: www.fda.gov

Language: English
38Leukemia / Minimal residual disease / Clinical trials / Medical research / Medical terms / Acute lymphoblastic leukemia / Surrogate endpoint / Biomarker / Personalized medicine / Medicine / Health / Pharmacology

Microsoft Word - Final Agenda for MRD workshop April[removed]doc

Add to Reading List

Source URL: www.fda.gov

Language: English
39Medical specialties / Clinical pharmacology / Food and Drug Administration / Pharmacology / United States Public Health Service / Physical therapy / Pediatrics / Surrogate endpoint / Medicine / Health / Medical terms

FDA ASK Children’s Workshop September 2010 Neil Friedman, MBChB Neurological Institute Cleveland Clinic

Add to Reading List

Source URL: www.fda.gov

Language: English
40Medical research / Clinical trials / Epidemiology / Medical terms / Pharmacology / Biomarker / Imaging biomarker / Surrogate endpoint / Personalized medicine / Medicine / Biology / Health

WHITE PAPER ESTABLISHING THE STANDARDS IN BIOMARKER RESEARCH.

Add to Reading List

Source URL: thomsonreuters.com

Language: English - Date: 2014-09-23 16:58:05
UPDATE